Back to Sites

Univ of São Paulo Brazil

Site Number

5074

Address

Univ. of Sao Paulo Brazil
Universidade de Sao Paulo
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
Av. Bandeirantes, 3900
Ribeirao Preto
São Paulo, 14.049-900
Brazil

IMPAACT Members at this Site

Studies at this Site

1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival)

DAIDS Number

10779

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1026S: PK in Pregnancy

DAIDS Number

Therapeutics

Research Area

Treatment

Study Status

Closed to Follow Up

P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity

DAIDS Number

10495

Research Area

Treatment

Study Status

Concluded

P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents

DAIDS Number

10669

Research Area

Complications & Comorbidities

Study Status

Concluded

P1083: Kaletra/Aluvia PK study

DAIDS Number

10787

Research Area

Treatment

Study Status

Concluded

P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine

DAIDS Number

10850

Research Area

Treatment

Study Status

Concluded

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Therapeutics

P1097: Raltegravir PK Study

DAIDS Number

11790

Research Area

Treatment

Study Status

Concluded

P1110: Safety and PK of RAL in Neonates

DAIDS Number

11891

Research Area

Treatment

Study Status

Concluded

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling